References
- Hussein MRA. Atypical lymphoid proliferations: the pathologist’s viewpoint. Expert Rev Hematol 2013;6(2):139-53
- Chang Q, Hedley D. Emerging applications of flow cytometry in solid tumor biology. Methods San Diego Calif. luglio 2012;57(3):359-67
- Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111(8):3941-67
- Stansfeld AG. The histological diagnosis of toxoplasmic lymphadenitis. J Clin Pathol 1961;14(6):565-73
- Contini C, Fainardi E, Cultrera R, et al. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis. J Neuroimmunol 2000;108(1-2):221-6
- Chen M, Aosai F, Mun HS, et al. Anti-HSP70 autoantibody formation by B-1 cells in Toxoplasma gondii-infected mice. Infect Immun 2000;68(9):4893-9
- Gibson SE, Swerdlow SH, Ferry JA, et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 2011;96(8):1144-52
- Shanafelt TD, Ghia P, Lanasa MC, et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010;24(3):512-20
- Pagni F, Zannella S, Valenzise V, et al. Occult monoclonal B-cell disorder of hyoid bone. Hematol Oncol 2014;32(2):107-9
- Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841-94
- Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004;103(12):4389-95
- Kil LP, Yuvaraj S, Langerak AW, Hendriks RW. The role of B cell receptor stimulation in CLL pathogenesis. Curr Pharm Des 2012;18(23):3335-55
- Badar T, Burger JA, Wierda WG, O’Brien S. Ibrutinib: a paradigm shift in management of CLL. Expert Rev Hematol 2014;7(6):705-17
- Awan FT, Byrd JC. New strategies in chronic lymphocytic leukemia: shifting treatment paradigms. Clin Cancer Res Off J Am Assoc Cancer Res 2014;20(23):5869-74